Veradermics, Incorporated (MANE) — Cash Flow-to-Debt Ratio
Latest as of March 2026:
-3.15x
Veradermics, Incorporated (MANE) has a Cash Flow-to-Debt Ratio of -3.15x as of March 2026, meaning its operating cash flow of $-21.17 Million could theoretically repay -3% of its total liabilities ($6.72 Million) in one year. See MANE financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-3.15x
Operating CF / Total Liabilities
Operating Cash Flow
$-21.17 Million
USD
Total Liabilities
$6.72 Million
USD
Data as of
Mar 2026
Most recent filing
Veradermics, Incorporated Cash Flow-to-Debt Ratio (2023–2025)
Historical debt coverage capacity for Veradermics, Incorporated across 3 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Veradermics, Incorporated.
Annual Cash Flow-to-Debt Ratio for Veradermics, Incorporated (2023–2025)
Year-by-year debt coverage analysis for Veradermics, Incorporated.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.26x | $-71.60 Million | $273.63 Million | ▲ +94.8% |
| 2024 | -5.02x | $-23.69 Million | $4.72 Million | ▼ -42.6% |
| 2023 | -3.52x | $-13.51 Million | $3.84 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.